RxDoctor Payments Data

Roger Hartl, MD

Neurological Surgery · New York, NYNPI 1043236623

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Medical Device Business Services, Inc. at 35.4% of the total. Reporting peaked in 2021 at $22,973 and has fallen 69.9% since, to $6,904 in 2025.

$96,680in general payments, 2019–2025

Across 155 payments — averaging $623.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$34K
  • Brainlab, Inc.$20K
  • Synthes GmbH$9K
  • Johnson & Johnson$8K
  • Carl Zeiss Meditec USA, Inc.$6K
  • Intrinsic Therapeutics$4K
  • plus $15K from 17 others
$200,000in ownership & investment interests, 2019–2025

Across 4 payments — averaging $50,000 each. An ownership or investment interest held by the physician or an immediate family member.

  • Durastat LLC$200K

What the payments were for

  • Royalty or licence$2,2292%
  • Consulting fees$57,08559%
  • Speaking & faculty fees$9,50710%
  • Grants$1,1751%
  • Travel & lodging$18,88720%
  • Food & beverage$7,7968%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$96,680 in reported general payments places this provider in the 85th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York

Medicare billing

Part B allowed, 2024
$402,903
Medicare patients
317
Services billed
800

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurological surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →